[Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Associated with Anterior Mediastinal Mature Teratoma]

Tatsuya Katayama1, Jun Amioka, Yoshinori Handa

  • 1Department of Thoracic Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan.

Insights

A young male developed anti-N-methyl-D-aspartate (NMDA) receptor encephalitis, a severe neurological condition, linked to an anterior mediastinal teratoma. Prompt tumor resection and immunotherapy led to significant recovery, highlighting the importance of early diagnosis and multidisciplinary care.

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Context:

  • Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a severe autoimmune neurological disorder.
  • It is often associated with teratomas, particularly in young adults.
  • This case presents a rare occurrence in a male patient with an anterior mediastinal teratoma.

Purpose:

  • To report a unique case of anti-NMDA receptor encephalitis in a young male.
  • To highlight the association between this encephalitis and an anterior mediastinal teratoma.
  • To emphasize the importance of prompt diagnosis and multidisciplinary treatment.

Summary:

  • A previously healthy 27-year-old male presented with psychiatric symptoms, progressing to meningoencephalitis requiring mechanical ventilation.
  • Diagnosis of anti-NMDA receptor encephalitis was confirmed by positive CSF anti-NMDA antibodies.
  • An anterior mediastinal cystic mass, later identified as a mature teratoma, was resected.
  • Post-operative treatment included plasmapheresis and steroids, leading to gradual neurological improvement and recovery.

Impact:

  • This case expands the known spectrum of anti-NMDA receptor encephalitis associations beyond ovarian teratomas.
  • It underscores the critical need for thorough diagnostic workups, including imaging for extragonadal teratomas, in suspected autoimmune encephalitis.
  • Successful treatment demonstrates the efficacy of combined surgical and immunomodulatory therapies for a favorable prognosis.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...